海创药业-U
(688302)
| 流通市值：21.15亿 | | | 总市值：28.79亿 |
| 流通股本：7272.45万 | | | 总股本：9901.56万 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 283,459,432.65 | 813,226,984.11 | 738,538,069.74 | 780,695,458.01 |
| 预付款项 | 33,543,452.08 | 30,051,912.07 | 37,455,439.54 | 28,827,074.13 |
| 其他应收款合计 | 969,593.8 | 1,386,277.85 | 1,437,005.73 | 1,416,622 |
| 存货 | 5,167.17 | 5,576.47 | 4,408.13 | 4,609.68 |
| 其他流动资产 | 17,082,259.5 | 11,933,571.05 | 17,978,049.74 | 14,345,572.64 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,071,353,141.04 | 1,147,226,484.99 | 1,265,783,898.54 | 1,342,547,791.24 |
| 非流动资产: | | | | |
| 其他非流动金融资产 | 7,032,308.8 | 7,032,308.8 | 5,000,000 | 5,000,000 |
| 固定资产 | 5,349,175.75 | 5,844,657.3 | 6,327,326.47 | 6,528,055.42 |
| 在建工程 | 198,771,698.18 | 169,538,426.17 | 136,642,280.25 | 117,432,534.71 |
| 使用权资产 | 11,584,924.94 | 12,606,446.67 | 13,659,332.07 | 14,712,217.47 |
| 无形资产 | 31,047,727.68 | 31,209,998.04 | 31,372,268.4 | 31,534,538.76 |
| 长期待摊费用 | 30,924.44 | 41,232.53 | 51,540.62 | 61,848.71 |
| 其他非流动资产 | 109,269,509.06 | 118,065,514.37 | 116,889,186.18 | 111,367,379.22 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 363,086,268.85 | 344,338,583.88 | 309,941,933.99 | 286,636,574.29 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 1,434,439,409.89 | 1,491,565,068.87 | 1,575,725,832.53 | 1,629,184,365.53 |
| 流动负债: | | | | |
| 短期借款 | - | - | 30,000,000 | 30,000,000 |
| 应付票据及应付账款 | 77,597,368.39 | 92,868,462.38 | 107,066,676.31 | 103,209,549.91 |
| 应付账款 | 77,597,368.39 | 92,868,462.38 | 107,066,676.31 | 103,209,549.91 |
| 应付职工薪酬 | 3,196,113.19 | 4,964,393.69 | 7,375,920.04 | 9,742,897.2 |
| 应交税费 | 978,767.59 | 1,215,105.73 | 1,086,518.3 | 286,565.17 |
| 其他应付款合计 | 5,046,125.53 | 4,028,661.84 | 4,231,045.65 | 4,268,864.49 |
| 一年内到期的非流动负债 | 3,758,081.02 | 3,768,232.22 | 4,128,014.28 | 4,308,746.78 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 90,576,455.72 | 106,844,855.86 | 153,888,174.58 | 151,816,623.55 |
| 非流动负债: | | | | |
| 租赁负债 | 9,209,636.87 | 9,079,863.79 | 9,603,038.67 | 10,275,010.56 |
| 递延收益 | 8,550,000 | 8,550,000 | 8,100,000 | 8,100,000 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 17,759,636.87 | 17,629,863.79 | 17,703,038.67 | 18,375,010.56 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 108,336,092.59 | 124,474,719.65 | 171,591,213.25 | 170,191,634.11 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 99,015,598 | 99,015,598 | 99,015,598 | 99,015,598 |
| 资本公积 | 2,564,382,977.56 | 2,558,181,560.49 | 2,538,957,565 | 2,520,946,144.73 |
| 其他综合收益 | 135,886.72 | 109,508.29 | 264,990.04 | 288,883.82 |
| 未分配利润 | -1,337,431,144.98 | -1,290,216,317.56 | -1,234,103,533.76 | -1,161,257,895.13 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,326,103,317.3 | 1,367,090,349.22 | 1,404,134,619.28 | 1,458,992,731.42 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,326,103,317.3 | 1,367,090,349.22 | 1,404,134,619.28 | 1,458,992,731.42 |
| 负债和股东权益合计 | 1,434,439,409.89 | 1,491,565,068.87 | 1,575,725,832.53 | 1,629,184,365.53 |
| 公告日期 | 2024-04-27 | 2024-04-13 | 2023-10-28 | 2023-08-31 |
| 审计意见(境内) | | 标准无保留意见 | | |